These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 33660512)
1. Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in Tumors. Trotta AM; Aurilio M; D'Alterio C; Ieranò C; Di Martino D; Barbieri A; Luciano A; Gaballo P; Santagata S; Portella L; Tomassi S; Marinelli L; Sementa D; Novellino E; Lastoria S; Scala S; Schottelius M; Di Maro S J Med Chem; 2021 Mar; 64(6):3449-3461. PubMed ID: 33660512 [TBL] [Abstract][Full Text] [Related]
2. A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency. Osl T; Schmidt A; Schwaiger M; Schottelius M; Wester HJ Theranostics; 2020; 10(18):8264-8280. PubMed ID: 32724470 [TBL] [Abstract][Full Text] [Related]
3. Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1. Rosestedt M; Velikyan I; Rosenström U; Estrada S; Åberg O; Weis J; Westerlund C; Ingvast S; Korsgren O; Nordeman P; Eriksson O Nucl Med Biol; 2021 Feb; 93():54-62. PubMed ID: 33321470 [TBL] [Abstract][Full Text] [Related]
5. Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN Cheng S; Lang L; Wang Z; Jacobson O; Yung B; Zhu G; Gu D; Ma Y; Zhu X; Niu G; Chen X Bioconjug Chem; 2018 Feb; 29(2):410-419. PubMed ID: 29254329 [TBL] [Abstract][Full Text] [Related]
6. Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors. Alshoukr F; Prignon A; Brans L; Jallane A; Mendes S; Talbot JN; Tourwé D; Barbet J; Gruaz-Guyon A Bioconjug Chem; 2011 Jul; 22(7):1374-85. PubMed ID: 21662976 [TBL] [Abstract][Full Text] [Related]
7. A radiogallium-DOTA-based bivalent peptidic ligand targeting a chemokine receptor, CXCR4, for tumor imaging. Sano K; Masuda R; Hisada H; Oishi S; Shimokawa K; Ono M; Fujii N; Saji H; Mukai T Bioorg Med Chem Lett; 2014 Mar; 24(5):1386-8. PubMed ID: 24491461 [TBL] [Abstract][Full Text] [Related]
8. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging. Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452 [TBL] [Abstract][Full Text] [Related]
9. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers. Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391 [TBL] [Abstract][Full Text] [Related]
10. Targeting of MMP2 activity in malignant tumors with a 68Ga-labeled gelatinase inhibitor cyclic peptide. Liu Q; Pan D; Cheng C; Zhang A; Ma C; Wang L; Zhang D; Liu H; Jiang H; Wang T; Xu Y; Yang R; Chen F; Yang M; Zuo C Nucl Med Biol; 2015 Dec; 42(12):939-44. PubMed ID: 26344861 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo characterization of three 68Ga- and 111In-labeled peptides for cholecystokinin receptor imaging. Roosenburg S; Laverman P; Joosten L; Eek A; Rutjes FP; van Delft FL; Boerman OC Mol Imaging; 2012; 11(5):401-7. PubMed ID: 22954184 [TBL] [Abstract][Full Text] [Related]
12. C-terminal-modified LY2510924: a versatile scaffold for targeting C-X-C chemokine receptor type 4. Suzuki K; Ui T; Nagano A; Hino A; Arano Y Sci Rep; 2019 Oct; 9(1):15284. PubMed ID: 31653903 [TBL] [Abstract][Full Text] [Related]
13. [ Lau J; Kwon D; Rousseau E; Zhang Z; Zeisler J; Uribe CF; Kuo HT; Zhang C; Lin KS; Bénard F Mol Pharm; 2019 Nov; 16(11):4688-4695. PubMed ID: 31545614 [TBL] [Abstract][Full Text] [Related]
14. N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging. Gourni E; Mansi R; Jamous M; Waser B; Smerling C; Burian A; Buchegger F; Reubi JC; Maecke HR J Nucl Med; 2014 Oct; 55(10):1719-25. PubMed ID: 25146125 [TBL] [Abstract][Full Text] [Related]
15. Homodimeric peptide radiotracer [ Chen X; Zhang Z; Wang L; Zhang J; Zhao T; Cai J; Dang Y; Guo R; Liu R; Zhou Y; Wei R; Lou X; Xia F; Ma D; Li F; Dai J; Li F; Xi L Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2338-2352. PubMed ID: 38411667 [TBL] [Abstract][Full Text] [Related]
16. Development of a New Folate-Derived Ga-68-Based PET Imaging Agent. Brand C; Longo VA; Groaning M; Weber WA; Reiner T Mol Imaging Biol; 2017 Oct; 19(5):754-761. PubMed ID: 28194631 [TBL] [Abstract][Full Text] [Related]
17. Development of a Ga-68 labeled PET tracer with short linker for prostate-specific membrane antigen (PSMA) targeting. Moon SH; Hong MK; Kim YJ; Lee YS; Lee DS; Chung JK; Jeong JM Bioorg Med Chem; 2018 May; 26(9):2501-2507. PubMed ID: 29655611 [TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Biological Evaluation of Liu F; Liu T; Xu X; Guo X; Li N; Xiong C; Li C; Zhu H; Yang Z Mol Pharm; 2018 Feb; 15(2):619-628. PubMed ID: 29278911 [TBL] [Abstract][Full Text] [Related]
19. Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A Cancer Biother Radiopharm; 2018 Feb; 33(1):8-16. PubMed ID: 29373046 [TBL] [Abstract][Full Text] [Related]